For Medical Professionals

Industry News

Mulling the marijuana munchies: How the brain flips the hunger switch
2/19/2015

The "munchies," or that uncontrollable urge to eat after using marijuana, appear to be driven by neurons in the brain that are normally involved in suppressing appetite, according to a new study by...

A breakthrough in nanotoxicology by INRS researchers
2/19/2015

Silver nanoparticles and inflammationWhereas resistance to antibiotics complicates certain treatments, antimicrobial silver nanoparticles (AgNP) are gaining popularity for medical use.

New study reveals how to improve chemotherapy use in prostate cancer
2/19/2015

Next generation chemotherapy for prostate cancer has unique properties that could make it more effective earlier in treatment if confirmed in clinical trialsProstate cancer is the second leading...

Lack of RNA 'editing' leads to melanoma growth and metastasis
2/19/2015

MD Anderson study finds regulated ADAR1 gene key contributorThe importance of RNA editing in melanoma has been demonstrated by scientists at The University of Texas MD Anderson Cancer Center.

Bile duct cancer study may pave way for new treatments
2/19/2015

Patients with bile duct cancer could be helped by a new class of experimental drug, a study has shown.

Cancer experience presents time for lifestyle changes in both survivors and family members
2/19/2015

After studying cancer survivors and their family caregivers, researchers at Case Western Reserve University conclude that the period between the final cancer treatment and first post-treatment...

Mayo Clinic: Molecule that provides cellular energy found key to aggressive thyroid cancer
2/19/2015

Cancer researchers at Mayo Clinic's campus in Jacksonville, Florida, have identified a molecule they say is important to survival of anaplastic thyroid carcinoma (ATC) -- a lethal tumor with no...

New study reveals how to improve chemotherapy use in prostate cancer
2/19/2015

Next generation chemotherapy for prostate cancer has unique properties that could make it more effective earlier in treatment if confirmed in clinical trialsProstate cancer is the second leading...

Lack of RNA 'editing' leads to melanoma growth and metastasis
2/19/2015

MD Anderson study finds regulated ADAR1 gene key contributorThe importance of RNA editing in melanoma has been demonstrated by scientists at The University of Texas MD Anderson Cancer Center.

Anticoagulant fondaparinux associated with lower risk of bleeding and death following heart attack compared to heparin
2/18/2015

Patients who experienced a certain type of heart attack who received the anticoagulant fondaparinux had a lower risk of major bleeding events and death both in the hospital and after six months...